Arhaus, Inc. (ARHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of Arhaus Inc (ARHS, Financial) fell 4.42% in mid-day trading on Oct 2. The stock reached an intraday low of $10.94, before recovering slightly to $11.24, down from its previous close of $11.76.
NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Arhaus faced challenging 2Q24 results with decelerating growth and decreased guidance, but management remains confident in long-term investments and market recovery. Despite the stock price being flat since January 2023, I maintain a Hold rating due to the stock's current overvaluation even when considering cycle-average earnings. The company experienced a significant drop in comparable sales and adjusted EBITDA, but continues to invest in store expansion and high-quality products.
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.